THC/CBD for Cannabis

St. Joseph's Healthcare Hamilton, Hamilton, Canada
Cannabis+2 More ConditionsTetrahydrocannabinol-Cannabidiol Combination - Drug
Eligibility
18+
All Sexes

Study Summary

This trial tests the effects of THC and CBD on healthy adults and those with chronic kidney disease, including those on dialysis.

Eligible Conditions
  • Cannabis
  • Dialysis
  • Chronic Kidney Disease

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
Phase 1

Study Objectives

18 Primary · 3 Secondary · Reporting Duration: 48 hours

48 hours
Adverse events
Blood pressure
Cannabidiol and its metabolites area under the curve
Cannabidiol and its metabolites dialytic clearance
Cannabidiol and its metabolites last detection time
Cannabidiol and its metabolites maximum concentration (Cmax)
Cannabidiol and its metabolites renal clearance
Cannabidiol and its metabolites time to Cmax
Heart rate
Other cannabinoids and their metabolites area under the curve
Other cannabinoids and their metabolites dialytic clearance
Other cannabinoids and their metabolites last detection time
Other cannabinoids and their metabolites maximum concentration (Cmax)
Other cannabinoids and their metabolites renal clearance
Other cannabinoids and their metabolites time to Cmax
Tetrahydrocannabinol and its metabolites area under the curve
Tetrahydrocannabinol and its metabolites dialytic clearance
Tetrahydrocannabinol and its metabolites last detection time
Tetrahydrocannabinol and its metabolites maximum concentration (Cmax)
Tetrahydrocannabinol and its metabolites renal clearance
Tetrahydrocannabinol and its metabolites time to Cmax

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

THC/CBD
1 of 1

Experimental Treatment

24 Total Participants · 1 Treatment Group

Primary Treatment: THC/CBD · No Placebo Group · Phase 1

THC/CBD
Drug
Experimental Group · 1 Intervention: Tetrahydrocannabinol-Cannabidiol Combination · Intervention Types: Drug

Trial Logistics

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 48 hours

Who is running the clinical trial?

McMaster UniversityLead Sponsor
835 Previous Clinical Trials
2,632,796 Total Patients Enrolled
Center for Medicinal Cannabis ResearchOTHER
17 Previous Clinical Trials
589 Total Patients Enrolled
1 Trials studying Cannabis
20 Patients Enrolled for Cannabis
Michael Walsh, MD, PhDPrincipal InvestigatorMcMaster University
1 Previous Clinical Trials
2,750 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Is the use of THC/CBD officially backed by regulatory approval?

"Our in-house team has rated the safety of THC/CBD to be a 1, signifying limited evidence for both efficacy and security." - Anonymous Online Contributor

Unverified Answer

Are any slots for enrollment in this research still available?

"As per clinicaltrials.gov, this medical experiment is now recruiting volunteers. The study was first posted on January 11th 2023 and modified most recently on February 14th of the same year." - Anonymous Online Contributor

Unverified Answer

To what extent is this experiment being utilized by participants?

"Affirmative. According to clinicaltrials.gov, this experiment is currently recruiting individuals who meet the criteria of participation. The study was initially posted on November 1st 2023 and has since been edited on February 14th 2023; 24 volunteers are required across a single site." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.